4D Molecular Therapeutics
FDMT
FDMT
64 hedge funds and large institutions have $665M invested in 4D Molecular Therapeutics in 2021 Q1 according to their latest regulatory filings, with 28 funds opening new positions, 13 increasing their positions, 13 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
2.55% more ownership
Funds ownership: 55.09% → 57.64% (+2.6%)
0% more repeat investments, than reductions
Existing positions increased: 13 | Existing positions reduced: 13
Holders
64
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$23.5M | |
| 2 | +$18.5M | |
| 3 | +$12.2M | |
| 4 |
LCM
Laurion Capital Management
New York
|
+$9.47M |
| 5 |
CC
Casdin Capital
New York
|
+$9.32M |
Top Sellers
| 1 | -$16M | |
| 2 | -$13.3M | |
| 3 | -$6.74M | |
| 4 |
O
OrbiMed
New York
|
-$5.18M |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
-$5.16M |